Quiz Ref ID Antidepressants (ADs) are widely used during gestation for the treatment of depression. In the United States, the prevalence of AD use during pregnancy increased from 5.7% in 1999 to 13.3% in 2003
1; in Canada, 4.5% of pregnant women reported using ADs between 2001 and 2006.
2 However, there is continued confusion regarding the appropriate use of ADs during this critical period. Gestational exposure to ADs has been associated with an increased risk of spontaneous abortion,
3 major congenital malformations,
4 prematurity,
5,6 low birth weight,
5,6 neonatal withdrawal,
7 and pregnancy-induced hypertension.
8 Discontinuation of ADs during pregnancy in women with severe depression was associated with relapse in some studies.
9 Nevertheless, up to 20% of women who continue to use ADs during pregnancy remain depressed,
10 suggesting a lack of efficacy in some pregnant women.